abrdn Life Sciences Investors
HQL
65 hedge funds and large institutions have $93.8M invested in abrdn Life Sciences Investors in 2021 Q1 according to their latest regulatory filings, with 12 funds opening new positions, 27 increasing their positions, 17 reducing their positions, and 11 closing their positions.
59% more repeat investments, than reductions
Existing positions increased: 27 | Existing positions reduced: 17
9% more first-time investments, than exits
New positions opened: 12 | Existing positions closed: 11
0.62% less ownership
Funds ownership: 20.87% → 20.25% (-0.62%)
3% less capital invested
Capital invested by funds: $97M → $93.8M (-$3.22M)
2% less funds holding
Funds holding: 66 → 65 (-1)
100% less funds holding in top 10
Funds holding in top 10: 1 → 0 (-1)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
AUB
Atlantic Union Bankshares
Glen Allen,
Virginia
|
+$1.73M |
| 2 |
AAM
Advisors Asset Management
Monument,
Colorado
|
+$902K |
| 3 |
Cetera Investment Advisers
Schaumburg,
Illinois
|
+$741K |
| 4 |
RJA
Raymond James & Associates
St Petersburg,
Florida
|
+$627K |
| 5 |
Invesco
Atlanta,
Georgia
|
+$479K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
1832 Asset Management
Toronto,
Ontario, Canada
|
-$2.87M |
| 2 |
Cohen & Steers
New York
|
-$1.23M |
| 3 |
AA
AQR Arbitrage
Greenwich,
Connecticut
|
-$1.16M |
| 4 |
Bank of America
Charlotte,
North Carolina
|
-$918K |
| 5 |
1CP
1607 Capital Partners
Richmond,
Virginia
|
-$891K |
HQL Hedge Fund Activity: Q1 2021 in Review
65 of the 5,711 institutional investors tracked by Wall St. Rank reported a position in abrdn Life Sciences Investors (HQL) for Q1 2021, worth a combined $93.8M — down 3.3% from $97M a quarter earlier.
Buyers outnumbered sellers: 12 funds opened new HQL positions and 11 closed out — a net gain of 1 holder — while 27 added to existing stakes and 17 trimmed.
The largest buyer was Atlantic Union Bankshares, adding an estimated $1.73M. The largest seller was 1832 Asset Management, cutting an estimated $2.87M.
- 65 institutional investors held abrdn Life Sciences Investors (HQL) as of Q1 2021, down from 66 in Q4 2020.
- Funds reported $93.8M of abrdn Life Sciences Investors stock for Q1 2021, down 3.3% quarter-over-quarter.
- 12 funds opened new abrdn Life Sciences Investors positions in Q1 2021 and 11 closed out, a net change of +1 holder.
- The largest abrdn Life Sciences Investors buyer in Q1 2021 was Atlantic Union Bankshares, an estimated $1.73M added.
- The largest abrdn Life Sciences Investors seller in Q1 2021 was 1832 Asset Management, an estimated $2.87M sold.
Based on aggregated 13F filings for Q1 2021.